Elekta AB Recieves U.S. Regulatory Approval For Treatment Planning On Leksell Gamma Knife(R) Perfexion(TM)

STOCKHOLM, Sweden--(BUSINESS WIRE)--July 13, 2006--On July 5, the U.S. Federal Drug Administration (FDA) announced a 510(k) pre-market clearance for Leksell GammaPlan® PFX(TM), the treatment planning system developed for Leksell Gamma Knife® Perfexion(TM).